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Abstract
We report the case of a 61-year-old man with sharp pain, tender mass at the left lower one-third posterior tibial region. The
patient has a 10-year history of multiple myeloma and related chemotherapy. A positron emission tomography computed
tomography and magnetic resonance imaging indicated the suspect of a posterior tibial nerve tumor. En bloc resection of
the tumor was performed under guidance of nerve stimulator without resecting nerve trunk. Active nerve was reserved
without any neuropathic pain. Histology revealed the presence of a peripheral schwannoma. In conclusion, the tibial nerve
schwannoma appeared to be a whole nerve mass, but meticulous dissection showed that this tibial nerve schwannoma was a
well-encapsulated tumor and can be separated from the nerve trunk with active nerve fibers reserved. Removal of the tumor
made patient free of pain and asymptomatic after surgery. The level of clinical evidence is 4.
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Introduction
Schwannomas are benign nerve sheath tumors that can be
associated with genetic syndromes such as neurofibromatosis type 2 (NF2) or can occur as a result of therapeutic irradiation. The location of the schwannoma and the associated
nerve can impact the quality of life. Schwannomas can be
associated with pain, paresthesia, and motor weakness.1 The
exact mechanism of schwannoma development is not fully
understood; one theory suggests that axons of peripheral
nerves exposed to repetitive mechanical trauma from nerve
compression and irritation are not able to realign properly or
contact with the injured axons, leading to Schwann cells
remaining in a continuous proliferative state.2 Schwannomas
can also be caused by loss of the NF2 tumor suppressor gene
leading to the development of multiple tumors of the nervous
system including schwannomas.3 Schwannomas occur most
commonly in the head and neck region, and are rarely found
in the extremities, but when they do occur in the extremities,
they tend to affect the sciatic or ulnar nerves.4 There are only
a few cases reported in the literature on tibial nerve schwannomas caused by injury.4 There is not a case report regarding
the presentation of a posterior tibial nerve schwannoma in

patients with advanced malignant processes of multiple
myeloma.
Herein, we present an unusual case of a posterior tibial
nerve schwannoma in a patient with a history of 10 years of
multiple myeloma and chemotherapy, which was diagnosed
in a close cooperation of the radiologist, orthopedic surgeon,
and pathologist.

Case report
Our patient is a 61-year-old Caucasian male, with a 10-year
history of multiple myeloma (IgM kappa multiple myeloma).
He presented to clinic with a sharp pain at left lower one-third
tibial region with a small mass (15 × 15 × 10 mm3) palpated,
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Figure 1. PET/CT shows hypermetabolic focus in the soft
tissues of the posterior left medial ankle (arrow).

he rated the pain score up to 10/10 based on visual analog
scale and described it as sharp shooting pain that radiates to
his toes and occasionally goes up to the proximal leg. On
physical exam, there is a palpable nodule proximal to the
medial malleolus with a positive Tinel’s sign upon percussion
of the tibial nerve. Pain has been going on for approximately
7 years and has been progressively worsening over time.
The patient was treated by chemotherapy using fludarabine and rituximab in 2009 without response, then followed
by a combination of bortezomib and dexamethasone, which
brought in an excellent partial remission. Currently, he was
treated by trametinib and lenalidomide.
Approximately 4 months before presenting to clinic, the
patient was examined by a whole-body positron emission
tomography computed tomography (PET/CT) scanning to
monitor the metastatic progression of multiple myeloma and
response to chemotherapy. PET/CT showed a hypermetabolic focus in the soft tissues of the posterior left medial
ankle (Figure 1). The lesion went undiagnosed by the oncologist and radiologist and the patient continued to experience
pain in the region until a magnetic resonance imaging (MRI)
scanning was performed 2 months after the PET/CT was
obtained. The left ankle contrast MRI showed a T1 hypointense (Figure 2) with mixed T2 hyperintense (Figure 3) mass
lesion noted in the posterior medial soft tissues of the distal
tibia, which demonstrated intense enhancement and abuts
the tibial nerve. This was measured approximately 2.2 cm in
maximum craniocaudad dimension (Figure 4) and approximately 1.9 × 1.0 cm2 in maximum axial dimension (Figure
4). Preoperative biopsy was performed indicative of the
mass to be schwannoma.
After careful assessment in a multidisciplinary team, the
patient was referred to a specialist foot surgeon, and the
tumor was surgically removed under general anesthesia.
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Figure 2. Sagittal T1 MRI image, showing tibial nerve lesion
(arrow head) and posterior tibial nerve (arrows) and tibia bone (T).

Figure 3. Sagittal STIR (short-TI inversion recovery) image
showing tibial nerve lesion with a longitudinal diameter of
22.3 mm, posterior tibial nerve (arrows), and tibia bone (T).

Prior to start of the surgical procedure an ultrasound was
used to localize the area of the tibial nerve lesion, which was
then marked using a skin marker. A longitudinal incision
was made 1 cm wide behind the medial malleolus in line
with the tibial nerve to expose the fascia of the tibial nerve.
An enlarged mass of posterior nerve was seen. A freer elevator was used to lift the fascia away from the nerve and neurovascular bundle. Meticulous dissection was carried on to
reserve the functional nerve fibers. A hemostat and blunt
tenotomy scissors were used to dissect the nerve lesion, and
the epineurium was gently incised longitudinally running in
line with the nerve fibers and was dissected and retracted

3

Daniel et al.

Figure 5. Surgical exposure and dissection of tibial nerve. The
mass is encapsulated together with the nerve.

Figure 4. Axial T2 MRI image showing a well-defined
hyperintense tibial nerve lesion measuring 9.5 mm × 19.3 mm.

extracapsularly. The epineural tissue layer was meticulously
dissected. It was found that the tumor surface can be exposed
and the whole tumor can be freed via blunt dissection from
the vascular bundle posterior medial distal leg (Figure 5).
Gentle dissection along the plane of the tumor capsule
from the epineural layers allowed the tumor to be shelled
out as a whole (Figure 6). The proximal and distal poles
were approached, and two fascicles were isolated and cut
from the nerve. A nerve stimulator (Vari-Stim III, nerve
locator; Medtronic Xomed Inc, Jacksonville, FL, USA) was
used to interrogate the nerve to identify the inactive nerve
fascicles. A well-encapsulated tumor and inactive nerve was
dissected and separated from the active nerve (Figure 7).
The tumor was an approximately 22 × 19 × 10 mm3 wellencapsulated and circumscribed lesion. The rest of the posterior nerve was reserved. The specimen was sent for
histopathological analysis. Next, a nerve stimulator was
used again to check the motor function of the foot, which
was noted to be intact.
The postoperative histopathological analysis of the specimen revealed bland spindle cells and hyalinized stroma.
Majority of the spindle cells were strongly immunoreactive
to S-100. A few cells were immunoreactive to epithelial
membrane antigen (EMA) (Figures 8 and 9). Neurofilament
(NF) immunostaining showed scattered entrapped axons.
The findings were consistent with the diagnosis of peripheral
nerve schwannoma.

Figure 6. Tibial nerve schwannoma dissection from surrounding
epineurium.

At 12 months of follow-up after surgery, the patient was
asymptomatic without pain or numbness and fully able to
walk without any limitation. No instability or muscular
weakness was present.

Discussion
In the present case study we report a rare case of multiple
myeloma accompanied with posterior tibial nerve schwannoma. Schwannomas can make up to 5.2% of all benign soft
tissue tumors in all areas of the body, and its predilection to
the foot and ankle region has a rate of 0.3% among all benign
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Figure 7. Schwannoma mass with size matching the measures
in MRI.

Figure 8. S100 positive immunostaining of schwannoma with
diffused dark brown-stained tumor cells (magnification ×40).

soft tissue tumors in the body.4,5 Peripheral schwannoma that
coexisted with multiple myeloma has not been reported in
the literature. Our case is the first case report regarding multiple myeloma accompanied with posterior tibial nerve
schwannoma.
Our surgical treatment indicates that the posterior tibial
nerve schwannoma can be encapsulated with the nerve trunk
that appeared to be a whole piece of mass; however, meticulous dissection of the tumor separates the circumscribed
lesions from the functional nerve trunk, and thus reserves
other normal functional nerve fibers. A nerve stimulator can
be used to interrogate the nerve to identify the inactive nerve
fascicles and save active nerve fibers.
Schwannomas are nerve sheath nonmalignant tumors.
Schwannomas may not need treatment if they are not causing any symptoms. Surgery is needed if the tumor is
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Figure 9. H&E stain of schwannoma (magnification ×100). Short
fascicles of spindle cells with eosinophilic cytoplasm with syncytial
appearance were found. These spindle cells were arranged in a
vague palisade pattern. On immunohistochemistry, these spindle
cells were immunoreactive to S100 protein.

pressing on a nerve causing pain or other problems. In this
case, the patient suffered significant pain; thus, surgery
was performed and after surgery patient is free of pain now
without neural deficit. Preoperative imaging and ultrasonic scanning are important for lesion localization but
cannot differentiate between schwannoma and other
lesions such as neurofibrosarcomas, which is a malignant
tumor. Preoperative biopsy can be performed for the differential diagnosis.
A schwannoma typically comes from a single bundle (fascicle) within the main nerve and displaces the rest of the
nerve. When a schwannoma grows larger, more fascicles are
affected, making removal more difficult.6 In our case, surgical procedures demonstrated that this patient’s schwannoma
is a well-encapsulated tumor that is adjacent to, but not associated with, the surrounding nerve fascicles; hence, surgical
resection of the schwannoma mass does not damage majority
of nerve fibers or lead to neural dysfunction. A nerve stimulator can be used intraoperatively to identify an area of inactive fascicles and avoid damaging a functional area of active
fascicles when making the epineural incision, thus minimizing the sensory and motor function loss of the tibial nerve
from the surgery.
Preoperative imaging and ultrasonic scanning are important for intraoperative localization. PET/CT scan can be used
for tumor diagnosis and MRI can be used to delineate the
anatomy of the tumor and localize it relative to the surrounding structures. A nerve stimulator was used intraoperatively
to identify an area of inactive fascicles and avoid damaging
a functional area of active fascicles when making the epineural incision, thus minimizing the sensory and motor function
loss of the tibial nerve from the surgery.
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It is not clear if there is an association between multiple
myeloma and the development of schwannoma. On immunohistochemistry stains, the spindled cells displayed diffuse,
strong nuclear and cytoplasmic positivity for S100 with a
few cells positive with EMA staining indicative of locally
formed myelin sheath neoplasm, hence ruling off the metastasis of multiple myeloma to the peripheral posterior tibial
nerve. The relationship between multiple myeloma and
peripheral nerve schwannoma is still inconclusive and
remained to be elucidated.
Limitation of this study is that ultrasound scanning was
not used for this patient. Ultrasound is widely used in the
musculoskeletal systems. Ultrasound can be also used for
scanning the nerve7,8 and might be more suitable than MRI
for following up the case and cost-effective.

Conclusion
We presented a case of posterior tibial nerve schwannoma with
coexisting multiple myeloma under chemotherapy. The tibial
nerve schwannoma appeared to be a posterior nerve mass, but
meticulous dissection showed that this tibial nerve schwannoma was a well-encapsulated tumor. The tumor was resected
with the rest of the nerve being reserved. Removal of the tumor
made patient free of pain and asymptomatic after surgery.
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